What is Cushing's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Cushing's Syndrome?

Cushing's syndrome is a rare endocrine disorder caused by chronic excessive exposure to glucocorticoid hormones, either from exogenous steroid use or endogenous overproduction of cortisol, with an estimated incidence of 2 to 8 per million people annually for endogenous causes. 1, 2

Definition and Core Pathophysiology

Cushing's syndrome represents a constellation of clinical manifestations resulting from prolonged hypercortisolism that is not due to normal physiological stress responses. 1, 3 The syndrome can arise from:

  • Exogenous sources: Chronic glucocorticoid medication use (most common overall cause) 1, 2
  • Endogenous sources: Autonomous cortisol overproduction from tumors or hyperplastic tissue 3, 2

Etiologic Classification

ACTH-Dependent Causes (60-80% of endogenous cases)

  • Cushing's disease: Pituitary corticotroph adenomas secreting ACTH, accounting for 60-70% of endogenous cases 1, 4
  • Ectopic ACTH syndrome: Non-pituitary tumors producing ACTH or CRH, with thymic sources representing up to 2% of cases 4, 5
  • Elevated ACTH levels indicate the cortisol excess originates from pituitary or ectopic sources rather than the adrenal gland itself 4, 5

ACTH-Independent Causes

  • Benign adrenal adenomas: Unilateral cortisol-secreting tumors that suppress ACTH production 4
  • Adrenal carcinomas: Suspected when tumors exceed 5 cm with irregular margins, inhomogeneity, or local invasion 4
  • Bilateral adrenal disease: Including primary pigmented nodular adrenal dysplasia or ACTH-independent macronodular hyperplasia 3
  • Suppressed ACTH levels indicate autonomous adrenal cortisol production 3

Clinical Manifestations

Classic Physical Features

The syndrome presents with characteristic signs including:

  • Dermatologic: Facial plethora, easy bruising, purple abdominal striae, fragile skin, hirsutism, and acne 6, 4, 1
  • Body habitus: Central weight gain, moon facies, dorsal and supraclavicular fat accumulation (buffalo hump) 6, 4, 1
  • Musculoskeletal: Proximal muscle weakness and protein catabolism 6, 5, 1

Metabolic and Cardiovascular Complications

  • Hypertension: Occurs in 70-90% of patients, driven by mineralocorticoid receptor activation from excess cortisol overwhelming protective enzymes, increased renal sodium absorption, renin-angiotensin system activation, and vascular sensitization to catecholamines 6, 4, 7
  • Glucose abnormalities: Exceed 80% prevalence, mimicking severe metabolic syndrome 6, 4
  • Dyslipidemia and cardiovascular disease: Contributing to increased mortality from myocardial infarction and cerebrovascular accidents 2, 8

Neuropsychiatric Manifestations

  • Mood disorders, depression, anxiety, and neurocognitive changes are common 6, 4, 1
  • These symptoms overlap significantly with other conditions, complicating diagnosis 4

Diagnostic Delay and Clinical Significance

The average diagnostic delay is 3 years from symptom onset, resulting in severe multisystem morbidity and increased mortality from cardiovascular events, pulmonary emboli, and infections. 4, 2, 8 This delay occurs because many features (weight gain, hypertension, mood changes) are common in the general population and may be attributed to other conditions like metabolic syndrome. 6, 4

Prevalence in Specific Populations

While Cushing's syndrome is rare in the general population, it may have higher prevalence in certain clinical contexts:

  • Up to 4% in patients with resistant hypertension 6
  • However, systematic screening of 423 resistant hypertension patients found no overt cases, suggesting it remains uncommon even in this high-risk group 6
  • Subclinical Cushing syndrome (abnormal dexamethasone suppression without overt symptoms) is the most common hormonal dysfunction in adrenal incidentalomas 6

Key Clinical Pitfall

The most critical pitfall is failing to exclude exogenous glucocorticoid use before pursuing extensive endogenous Cushing's syndrome workup, as iatrogenic causes are far more common than endogenous overproduction. 5, 1

References

Research

Cushing syndrome.

Nature reviews. Disease primers, 2025

Research

Cushing's disease.

Best practice & research. Clinical endocrinology & metabolism, 2009

Guideline

Cushing Syndrome Pathogenesis and Clinical Consequences

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Paraneoplastic Cushing Syndrome Diagnosis and Clinical Features

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Metabolic Derangements in Cushing Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cushing's Syndrome: Rapid Evidence Review.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.